{
  "id": 16395081,
  "title": "Who is After NAFDAC DG, Prof. Adeyeye?",
  "url": "https://urgent.news/2026/10/24/who-is-after-nafdac-dg-prof-adeyeye",
  "topic": "world",
  "section": "World",
  "published": "2026-10-24T23:57:23.000Z",
  "source": {
    "name": "This Day",
    "slug": "this-day",
    "url": "https://www.thisdaylive.com/2026/10/25/who-is-after-nafdac-dg-prof-adeyeye/"
  },
  "original_language": "en",
  "account": "The National Agency for Food and Drug Administration and Control (NAFDAC) Director-General, Professor Mojisola Adeyeye, is currently facing intense scrutiny and criticism, potentially endangering her position. Her aggressive stance against fake drug merchants and sachet alcohol has ignited controversy, leading to accusations of overreaching regulatory authority. Supporters assert that NAFDAC's crackdown on sachet alcohol and other small container alcoholic products may have provoked backlash from commercial stakeholders, while detractors argue the resistance is a sign of public health policies clashing with powerful commercial interests. Despite the storm of criticism, it's crucial to differentiate between mere suspicion and concrete proof of a conspiracy against Adeyeye; her policies and leadership remain valid subjects of public scrutiny. As Nigeria grapples with the balance between public health imperatives, commercial interests, and institutional accountability, the fate of NAFDAC's chief remains uncertain, leaving the public to ponder the enigma surrounding her predicament.",
  "summary": "Indeed, every battle has its casualties, every throne its intrigues, and every crusader his or her fair share of enemies. For the Director-General of the National Agency for Food and",
  "key_points": [
    "NAFDAC DG, Prof. Adeyeye, under intense scrutiny",
    "Aggressive stance against fake drugs and sachet alcohol",
    "Critics accuse overreach, supporters see commercial backlash"
  ],
  "editors_take": "The intense scrutiny facing the NAFDAC chief signals a growing conflict between aggressive public health enforcement and the powerful commercial interests protected by existing regulatory loopholes.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}